• Given delays in payment, the production and shipment of second-line drugs are often delayed. Bridge financing can offer a solution in the short term. Initial up-front deposits, guaranteed order volumes, options pricing, and the ability to purchase later are all innovative ideas for addressing current challenges in supply chain financing.
  • Supply chains can be improved by forecasting future utilization through data-driven state-level micro-planning; incorporating DOTS-Plus geographic, time-based expansion of services; and increasing laboratory capacity.
  • Maintaining transparency of information and data with suppliers can drive down costs.
  • The harmonization of quality standards to create a homogeneous marketplace has the potential to create demand at a sufficient level of quality.
  • Aggregating risk by global ordering, rather than country-by-country ordering, would improve the supply chain as part of a global architecture that would innovate drug procurement procedures.
  • A virtual rotating stockpile may help prevent stockouts.
  • Effective forecasting would help quantify risk.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement